Hologic, Inc. (BIT:1HOLX)
Italy
· Delayed Price · Currency is EUR 56.50
0.00 (0.00%)
At close: Jun 26, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 28, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 24, 2022 | Sep '21 Sep 25, 2021 | Sep '20 Sep 26, 2020 | 2013 - 2019 |
Diagnostics | 1.78B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Growth | 3.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Breast Health | 1.52B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Breast Health Growth | 0.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
GYN Surgical | 641.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
GYN Surgical Growth | 4.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Skeletal Health | 84.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Skeletal Health Growth | -25.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 100.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 100.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 100.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 28, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 24, 2022 | Sep '21 Sep 25, 2021 | Sep '20 Sep 26, 2020 | 2013 - 2019 |
Other | 1.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Capital Expenditures | 80.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Capital Expenditures Growth | 34.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Breast Health Capital Expenditures | 30.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Breast Health Capital Expenditures Growth | -44.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
GYN Surgical Capital Expenditures | 16.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
GYN Surgical Capital Expenditures Growth | 268.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Skeletal Health Capital Expenditures | 1.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Skeletal Health Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 28, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 24, 2022 | Sep '21 Sep 25, 2021 | Sep '20 Sep 26, 2020 | 2013 - 2019 |
Other | 87.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 87.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Operating Income | 303.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Diagnostics Operating Income Growth | 452.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Breast Health Operating Income | 394.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Breast Health Operating Income Growth | 22.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
GYN Surgical Operating Income | 185.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
GYN Surgical Operating Income Growth | -88.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Skeletal Health Operating Income | -500.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Skeletal Health Operating Income Growth | -162.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 87.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|